Tripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical use

AbstractThe development of skin-care products is recently growing. Cosmetic formulas containing active ingredients with proven efficacy, namely cosmeceuticals, are based on various compounds, including peptides. Different whitening agents featuring anti-tyrosinase activity have been applied in the c...

Full description

Bibliographic Details
Main Authors: Patrycja Ledwoń, Waldemar Goldeman, Katarzyna Hałdys, Michał Jewgiński, Greta Calamai, Joanna Rossowska, Anna Maria Papini, Paolo Rovero, Rafał Latajka
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/14756366.2023.2193676
_version_ 1797400946551029760
author Patrycja Ledwoń
Waldemar Goldeman
Katarzyna Hałdys
Michał Jewgiński
Greta Calamai
Joanna Rossowska
Anna Maria Papini
Paolo Rovero
Rafał Latajka
author_facet Patrycja Ledwoń
Waldemar Goldeman
Katarzyna Hałdys
Michał Jewgiński
Greta Calamai
Joanna Rossowska
Anna Maria Papini
Paolo Rovero
Rafał Latajka
author_sort Patrycja Ledwoń
collection DOAJ
description AbstractThe development of skin-care products is recently growing. Cosmetic formulas containing active ingredients with proven efficacy, namely cosmeceuticals, are based on various compounds, including peptides. Different whitening agents featuring anti-tyrosinase activity have been applied in the cosmeceutical field. Despite their availability, their applicability is often limited due to several drawbacks including toxicity, lack of stability, and other factors. In this work, we present the inhibitory effect on diphenolase activity of thiosemicarbazone (TSC)-peptide conjugates. Tripeptides FFY, FWY, and FYY were conjugated with three TSCs bearing one or two aromatic rings via amide bond formation in a solid phase. Compounds were then examined as tyrosinase and melanogenesis inhibitors in murine melanoma B16F0 cell line, followed by the cytotoxicity assays of these cells. In silico investigations explained the differences in the activity, observed among tested compounds. Mushroom tyrosinase was inhibited by TSC1-conjugates at micromolar level, with IC50 lower than this for kojic acid, a widely used reference compound. Up to now, this is the first report regarding thiosemicarbazones conjugated with tripeptides, synthesised for the purpose of tyrosinase inhibition.
first_indexed 2024-03-09T02:02:51Z
format Article
id doaj.art-72c5d9c7730f47889829d5a2f1611826
institution Directory Open Access Journal
issn 1475-6366
1475-6374
language English
last_indexed 2024-03-09T02:02:51Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Enzyme Inhibition and Medicinal Chemistry
spelling doaj.art-72c5d9c7730f47889829d5a2f16118262023-12-08T03:24:22ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742023-12-0138110.1080/14756366.2023.2193676Tripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical usePatrycja Ledwoń0Waldemar Goldeman1Katarzyna Hałdys2Michał Jewgiński3Greta Calamai4Joanna Rossowska5Anna Maria Papini6Paolo Rovero7Rafał Latajka8Department of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wrocław, PolandDepartment of Organic and Medicinal Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wrocław, PolandDepartment of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wrocław, PolandDepartment of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wrocław, PolandInterdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Neurosciences, Psychology, Drug Research and Child Health Section of Pharmaceutical Sciences and Nutraceutics, University of Florence, Sesto Fiorentino, ItalyLudwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Science, Wrocław, PolandInterdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Chemistry “Ugo Schiff”, University of Florence, Sesto Fiorentino, ItalyInterdepartmental Research Unit of Peptide and Protein Chemistry and Biology, Department of Neurosciences, Psychology, Drug Research and Child Health Section of Pharmaceutical Sciences and Nutraceutics, University of Florence, Sesto Fiorentino, ItalyDepartment of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Science and Technology, Wrocław, PolandAbstractThe development of skin-care products is recently growing. Cosmetic formulas containing active ingredients with proven efficacy, namely cosmeceuticals, are based on various compounds, including peptides. Different whitening agents featuring anti-tyrosinase activity have been applied in the cosmeceutical field. Despite their availability, their applicability is often limited due to several drawbacks including toxicity, lack of stability, and other factors. In this work, we present the inhibitory effect on diphenolase activity of thiosemicarbazone (TSC)-peptide conjugates. Tripeptides FFY, FWY, and FYY were conjugated with three TSCs bearing one or two aromatic rings via amide bond formation in a solid phase. Compounds were then examined as tyrosinase and melanogenesis inhibitors in murine melanoma B16F0 cell line, followed by the cytotoxicity assays of these cells. In silico investigations explained the differences in the activity, observed among tested compounds. Mushroom tyrosinase was inhibited by TSC1-conjugates at micromolar level, with IC50 lower than this for kojic acid, a widely used reference compound. Up to now, this is the first report regarding thiosemicarbazones conjugated with tripeptides, synthesised for the purpose of tyrosinase inhibition.https://www.tandfonline.com/doi/10.1080/14756366.2023.2193676Tyrosinasethiosemicarbazonespeptide conjugatescosmeceuticals melanogenesis
spellingShingle Patrycja Ledwoń
Waldemar Goldeman
Katarzyna Hałdys
Michał Jewgiński
Greta Calamai
Joanna Rossowska
Anna Maria Papini
Paolo Rovero
Rafał Latajka
Tripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical use
Journal of Enzyme Inhibition and Medicinal Chemistry
Tyrosinase
thiosemicarbazones
peptide conjugates
cosmeceuticals melanogenesis
title Tripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical use
title_full Tripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical use
title_fullStr Tripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical use
title_full_unstemmed Tripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical use
title_short Tripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical use
title_sort tripeptides conjugated with thiosemicarbazones new inhibitors of tyrosinase for cosmeceutical use
topic Tyrosinase
thiosemicarbazones
peptide conjugates
cosmeceuticals melanogenesis
url https://www.tandfonline.com/doi/10.1080/14756366.2023.2193676
work_keys_str_mv AT patrycjaledwon tripeptidesconjugatedwiththiosemicarbazonesnewinhibitorsoftyrosinaseforcosmeceuticaluse
AT waldemargoldeman tripeptidesconjugatedwiththiosemicarbazonesnewinhibitorsoftyrosinaseforcosmeceuticaluse
AT katarzynahałdys tripeptidesconjugatedwiththiosemicarbazonesnewinhibitorsoftyrosinaseforcosmeceuticaluse
AT michałjewginski tripeptidesconjugatedwiththiosemicarbazonesnewinhibitorsoftyrosinaseforcosmeceuticaluse
AT gretacalamai tripeptidesconjugatedwiththiosemicarbazonesnewinhibitorsoftyrosinaseforcosmeceuticaluse
AT joannarossowska tripeptidesconjugatedwiththiosemicarbazonesnewinhibitorsoftyrosinaseforcosmeceuticaluse
AT annamariapapini tripeptidesconjugatedwiththiosemicarbazonesnewinhibitorsoftyrosinaseforcosmeceuticaluse
AT paolorovero tripeptidesconjugatedwiththiosemicarbazonesnewinhibitorsoftyrosinaseforcosmeceuticaluse
AT rafałlatajka tripeptidesconjugatedwiththiosemicarbazonesnewinhibitorsoftyrosinaseforcosmeceuticaluse